Emerging tumors exhibit uniform distribution of T cells and NK cells in the TME. Humanized mouse xenograft tumors were harvested 27 days after tumor inoculation. IHC staining for hematoxylin and eosin, along with specific markers for CD3 (A), CD16 (B), and CD56 (C), was used to assess the distribution of immune cells within the TME.